Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 29, 2019 Off

Uni-Bio Science Group Limited: 2018 Annual Results

By BusinessWire

Enhanced Market Penetration of Core Marketed Products Pipeline Products Witnessed a Steady Progress to Launch Commencement of CMO Service to…

March 29, 2019 Off

Celgene Settles U.S. REVLIMID® Patent Litigation with Alvogen

By BusinessWire

Alvogen licensed to sell volume-limited amounts of generic lenalidomide in the U.S. beginning on a confidential date after the March…

March 29, 2019 Off

Global Anticoagulants Market Report, 2019: Industry Size & Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies (2018-2026) – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Anticoagulants Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,…

March 29, 2019 Off

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Bristol-Myers Squibb Shareholders Vote “FOR” Proposed Merger with Celgene

By BusinessWire

Bristol-Myers Squibb Urges Shareholders to Vote “FOR” the Merger-Related Proposals on the WHITE Proxy Card Today NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb…

March 29, 2019 Off

Definiens and Ultivue Announce a Collaboration to Co-Develop Joint Offerings in Multiplexed Immunofluorescence (IF) and AI Enabled Digital Image Analysis

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens,…

March 29, 2019 Off

DKT Introduced DKT WomanCare at the 19th Reproductive Health Supplies Coalition Annual Meeting in Kathmandu, Nepal

By BusinessWire

With a website unveiled at the Innovation Expo and a presentation by its Regulatory Affairs Director, new DKT International program…

Boehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD Therapeutics
March 29, 2019 Off

Boehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD Therapeutics

By BusinessWire

New molecular platform to access intracellular targets across a broad range of tumor cell types Opens up new range of…

MedPharm to develop Destiny Pharma’s formulations from XF-platform
March 29, 2019 Off

MedPharm to develop Destiny Pharma’s formulations from XF-platform

By Dino Mustafić

Destiny Pharma has picked MedPharm to develop new topical formulations of its novel XF-platform compounds, new treatments for dermal and ocular infections which are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR).

Celgene Receives CHMP Positive Opinions for Both REVLIMID® (lenalidomide) and IMNOVID® (pomalidomide)-Based Triplet Combination Regimens for Patients with Multiple Myeloma
March 29, 2019 Off

Celgene Receives CHMP Positive Opinions for Both REVLIMID® (lenalidomide) and IMNOVID® (pomalidomide)-Based Triplet Combination Regimens for Patients with Multiple Myeloma

By BusinessWire

The CHMP adopted two positive opinions recommending European Commission approval of: REVLIMID in combination with bortezomib and dexamethasone (RVd) in…

March 29, 2019 Off

Metagenomics Market to 2027 – Global Analysis & Forecasts by Product, Application and Geography – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Metagenomics Market to 2027 – Global Analysis and Forecasts by Product, Application and Geography” report has been added…

Posts pagination

Previous 1 … 3,319 3,320 3,321 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine